Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Depreciation & Amortization (CF) (2016 - 2025)

Haemonetics (HAE) has 17 years of Depreciation & Amortization (CF) data on record, last reported at $27.4 million in Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) fell 5.65% year-over-year to $27.4 million; the TTM value through Dec 2025 reached $112.6 million, down 2.1%, while the annual FY2025 figure was $115.6 million, 18.9% up from the prior year.
  • Depreciation & Amortization (CF) reached $27.4 million in Q4 2025 per HAE's latest filing, down from $28.3 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $29.2 million in Q3 2024 and bottomed at $21.9 million in Q2 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $25.5 million, with a median of $24.6 million recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization (CF): decreased 23.83% in 2021, then increased 26.96% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $23.5 million in 2021, then grew by 0.15% to $23.6 million in 2022, then fell by 0.17% to $23.5 million in 2023, then grew by 23.35% to $29.0 million in 2024, then fell by 5.65% to $27.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation & Amortization (CF) were $27.4 million in Q4 2025, $28.3 million in Q3 2025, and $28.8 million in Q2 2025.